Sotera Health Company provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for the medical device, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.
Resilient Performance | Sotera Health demonstrates financial strength with a 2.75 current ratio and 54.73% gross profit margin, showcasing operational resilience amid challenges |
Litigation Landscape | Explore the evolving legal terrain for Sotera Health, with stable case counts in California and anticipated trial results in Georgia shaping future prospects |
Strategic Compliance | Delve into Sotera's proactive approach to NESHAP regulations, potentially enhancing competitive edge and mitigating future litigation risks in sterilization services |
Growth Projections | Analyst targets range from $16 to $18, with a revised organic CAGR of 5-7% for 2025-2027 and ambitious free cash flow goals exceeding $500 million |
Metrics to compare | SHC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSHCPeersSector | |
---|---|---|---|---|
P/E Ratio | 186.8x | −2.5x | −0.5x | |
PEG Ratio | −4.71 | −0.01 | 0.00 | |
Price/Book | 8.8x | 1.1x | 2.6x | |
Price / LTM Sales | 4.0x | 2.4x | 3.3x | |
Upside (Analyst Target) | 4.7% | 32.2% | 40.6% | |
Fair Value Upside | Unlock | 24.6% | 5.3% | Unlock |